- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03079856
Drug Use and Sexual Risk Behaviors Among Emerging Adults in the ER
August 28, 2018 updated by: Erin Bonar, University of Michigan
This project will develop a technology-augmented HIV and substance use risk reduction intervention for delivery in the Emergency Department, a medical setting where at-risk emerging adults who use drugs and engage in HIV-related risk behaviors are likely to present.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Research regarding substance use (including illicit drugs and non-medical use of prescription drugs) and HIV-related sexual risk behaviors (HIV SRBs; e.g., inconsistent condom use, multiple partners, sex while intoxicated; and prevention of injection drug use) among emerging adults (EAs; ages 18-25) has generally focused on alcohol use among college students from campus settings; however, substance use and HIV (and other associated Sexually Transmitted Infections) disproportionately occur among young people living in urban, low-resource communities, particularly individuals of racial minorities.
The Emergency Department (ED) is a critical venue for accessing at-risk EAs engaging in substance use and HIV risk behaviors.
Research shows high rates of substance use and HIV SRBs among EA patients in the ED, yet no intervention exists for EAs in this setting.
The ED may be the only opportunity to intervene with these young people because EAs in urban, low-resource settings often lack a primary care provider during the transition from pediatric to adult medicine, may be un-insured or under-insured, and may not be involved in a traditional college campus setting.
Further the use of technology (e.g., mobile phones) is relatively ubiquitous among this age group, and most prefer technology-based communication (e.g., text messaging or instant messaging via apps), therefore interventions for EAs may be enhanced by this type of technology.
In this phase we will test a tailored intervention for EA patients in the ED focusing on reducing substance use and HIV SRBs, which will be enhanced through the use of mobile app notifications.
Study Type
Interventional
Enrollment (Actual)
63
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Michigan
-
Flint, Michigan, United States, 48503
- Hurley Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 25 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Medically stable
- Mentally and physically able to consent
- English-speaking
- Between ages 18-25
- Past-month substance use (including illicit drugs and/or non-medical prescription drug use) and inconsistent condom use in the past month
- Ownership of a smartphone
Exclusion Criteria:
- ED presentation suicidality and/or acute psychosis, being in police custody, or present with psychological distress requiring intensive social work (e.g. sexual assault)
- Patients with a significant other that they live with who is currently participating in study
- Actively participating in another study
- Participated in prospective and intervention development phases of the study
- Married
- Do not wish to consent to audio-taping the in-person portion of the ED-based intervention session
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Brief Intervention
ED-based computer-guided intervention for substance use and HIV risk reduction utilizing Motivational Interviewing
|
Intervention for emerging adults (EAs) seeking care in the ED.
The intervention will be rooted in motivational interviewing (MI) and will be guided by social cognitive, self-determination, and the trans-theoretical theories.
The ED visit presents a "teachable moment" for intervening to promote health behavior, therefore eligible EAs will receive a ~30 minute MI-based session in the ED.
In order to capitalize on and potentially extend this moment, participants will receive daily booster notifications delivered through a secure mobile app that they will download to their phone at enrollment.
|
No Intervention: Enhanced Usual Care
Substance use and sexual health services information within a brochure provided to participants
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in days substance use
Time Frame: 2-months post baseline
|
60-day Timeline Follow-Back (TLFB) will be used to assess total days of any substance use.
|
2-months post baseline
|
Change in quantity of marijuana use
Time Frame: 2-months post baseline
|
60-day Timeline Follow-Back (TLFB) will be used to assess quantity of marijuana consumed.
|
2-months post baseline
|
Change in total alcohol consumption
Time Frame: 2-months post baseline
|
60-day Timeline Follow-Back (TLFB) will be used to assess quantity of alcohol consumed
|
2-months post baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in HIV risk behaviors
Time Frame: 2-months post baseline
|
60-day Timeline Follow-Back (TLFB) will be used to assess frequency of unprotected sex.
|
2-months post baseline
|
Change in substance use consequences
Time Frame: 2-months post baseline
|
Modified Rutgers Alcohol Problems Index adapted for alcohol and drugs will assess total substance related consequences experienced.
|
2-months post baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Erin E Bonar, Ph.D., University of Michigan
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 9, 2017
Primary Completion (Actual)
August 13, 2018
Study Completion (Actual)
August 13, 2018
Study Registration Dates
First Submitted
February 27, 2017
First Submitted That Met QC Criteria
March 8, 2017
First Posted (Actual)
March 15, 2017
Study Record Updates
Last Update Posted (Actual)
August 29, 2018
Last Update Submitted That Met QC Criteria
August 28, 2018
Last Verified
August 1, 2018
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- NIDA036008
- 4K23DA036008-04 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Drug Use
-
University of California, Los AngelesInstituto Nacional de Psiquiatría Dr. Ramón de la FuenteCompletedDrug Use | Harmful Use
-
University of California, Los AngelesCompleted
-
Hamad Medical CorporationPrimary Health Care Corporation, QatarRecruiting
-
Umeå UniversityRegion VästerbottenNot yet recruiting
-
University of California, Los AngelesNational Institute on Drug Abuse (NIDA); Medical University of South Carolina; University of ArkansasRecruitingDrug UseUnited States
-
PT. Kimia Farma (Persero) TbkPT Pharma Metric LabsCompleted
-
PT BernofarmPT Pharma Metric LabsCompleted
-
Ain Shams UniversityRecruiting
-
PT Kalbe Farma TbkPT Pharma Metric LabsCompleted
-
Assistance Publique Hopitaux De MarseilleUnknown
Clinical Trials on Brief Intervention
-
i4HealthTerminated
-
New York State Psychiatric InstituteNot yet recruitingDepression | Mental Health Disorder | Adolescent Behavior | Stigma, SocialUnited States
-
University of Texas at AustinNational Institute on Drug Abuse (NIDA)Completed
-
Friends Research Institute, Inc.National Institute on Drug Abuse (NIDA)CompletedDrug Abuse | HIV Risk BehaviorUnited States
-
Wayne State UniversityNational Institute on Drug Abuse (NIDA)Completed
-
Friends Research Institute, Inc.National Institute on Drug Abuse (NIDA)CompletedRisk Behavior | Marijuana Use | Alcohol Consumption | Unsafe Sex
-
University of California, San FranciscoCompletedMetabolic HealthUnited States
-
University of Dublin, Trinity CollegeCompletedSpondylitis, AnkylosingIreland
-
New York State Psychiatric InstituteNot yet recruitingDepression | Mental Health Disorder | Stigma, SocialUnited States
-
New York State Psychiatric InstituteNorthwell HealthCompletedAlcohol Use DisorderUnited States